Advertisement
Advertisement

HURA

HURA logo

TuHURA Biosciences, Inc. Common Stock

2.38
USD
Sponsored
-0.02
-0.83%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

2.34

-0.04
-1.81%

TuHURA Biosciences, Inc. Common Stock Profile

About

TuHURA Biosciences Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. TuHURA Biosciences Inc., formerly known as Kintara Therapeutics Inc., is based in SAN DIEGO.

Info & Links

CEO

James A. Bianco

Headquarters

10500 UNIVERSITY CENTER DR.,SUITE 110
TAMPA, FL 33612, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://tuhurabio.com

Auditor

Cherry Bekaert LLP

Share holders

883

Employees

22

TuHURA Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

148.83M

Enterprise Value

145.40M

Enterprise Value/EBITDA(ttm)

-4.65

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.76

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-182.40%

Return on Invested Capital(ttm)

-200.00%

Return on Assets(ttm)

-117.49%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-31.24M

Net Income Available to Common(ttm)

-30.06M

Diluted EPS(ttm)

-0.63

Share Statistics

Beta (5Y Monthly)

-0.32

52-Week Change

-39.44%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

63.58M

Dividend Yield

0.00%

Float4

63.45M

% Held by Insiders

0.20%

% Held by Institutions

0.62%

Balance Sheet

Total Cash(mrq)

3.62M

Total Cash Per Share(mrq)

0.06

Total Debt(mrq)

197.40K

Total Debt/Equity(mrq)

2.94%

Current Ratio(mrq)

0.40%

Quick Ratio(mrq)

0.78%

Book Value Per Share(mrq)

0.33

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.44

Free Cash Flow(ytd)

-23.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement